Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors

• Published in: BMC medical genomics Vol. 12; no. Suppl 8; pp. 175 - 12
• Main Authors: Jin, Young-Joo, Byun, Seyoun, Han, Seonggyun, Chamberlin, John, Kim, Dongwook, Kim, Min Jung, Lee, Younghee
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 20.12.2019; BioMed Central; BMC
• Subjects: Alcohol; Alternative splicing; Alternative splicing, hepatitis B virus; Cancer; Cancer genetics; Carcinogenesis; Carcinoma; Drinking (Alcoholic beverages); Epigenetics; Genes; Genetic aspects; Genetic engineering; Genomes; Genomics; Health aspects; Hepatitis; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C virus; Hepatocellular carcinoma; Histocompatibility antigen HLA; HLA antigens; Immune system; Liver cancer; Medical law; Messenger RNA; Molecular modelling; Ontology; Pathogenesis; Patients; Proteins; Risk factors; RNA; RNA-sequencing; Statistical analysis; Transcription; United States; RNA-sequencing; Alcohol; Hepatocellular carcinoma; Hepatitis C virus; Alternative splicing, hepatitis B virus
• ISSN: 1755-8794; 1755-8794
• DOI: 10.1186/s12920-019-0635-z

Hepatitis B virus (HBV), hepatitis C virus (HCV), and alcohol consumption are predominant causes of hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying how differently these causes are implicated in HCC development are not fully understood. Therefore, we investigated differential alternative splicing (AS) regulation among HCC patients with these risk factors. We conducted a genome-wide survey of AS events associated with HCCs among HBV (n = 95), HCV (n = 47), or alcohol (n = 76) using RNA-sequencing data obtained from The Cancer Genome Atlas. In three group comparisons of HBV vs. HCV, HBV vs. alcohol, and HCV vs. alcohol for RNA seq (ΔPSI> 0.05, FDR < 0.05), 133, 93, and 29 differential AS events (143 genes) were identified, respectively. Of 143 AS genes, eight and one gene were alternatively spliced specific to HBV and HCV, respectively. Through functional analysis over the canonical pathways and gene ontologies, we identified significantly enriched pathways in 143 AS genes including immune system, mRNA splicing-major pathway, and nonsense-mediated decay, which may be important to carcinogenesis in HCC risk factors. Among eight genes with HBV-specific splicing events, HLA-A, HLA-C, and IP6K2 exhibited more differential expression of AS events (ΔPSI> 0.1). Intron retention of HLA-A was observed more frequently in HBV-associated HCC than HCV- or alcohol-associated HCC, and intron retention of HLA-C showed vice versa. Exon 3 (based on ENST00000432678) of IP6K2 was less skipped in HBV-associated in HCC compared to HCV- or alcohol-associated HCC. AS may play an important role in regulating transcription differences implicated in HBV-, HCV-, and alcohol-related HCC development.